Webinar May 18, 2017 1-2pm CDT
Over the last decade, there has been increasing awareness among healthcare providers that adolescent girls and women with bleeding symptoms should be evaluated for congenital bleeding disorders, such as von Willebrand disease (VWD), hemophilia carrier status,
qualitative platelet disorders and rare bleeding disorders. The number of women and girls diagnosed with bleeding disorders and cared for at federally supported Hemophilia Treatment Centers grew by nearly 350% in the decade after 1990 and continues to grow exponentially. Unfortunately, diagnostic delays and misdiagnoses in this population are still common.